Prognostic Value of Ki-67 for Recurrence and Progression of Superficial Bladder Cancer
- 1 August 1997
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 158 (2) , 385-388
- https://doi.org/10.1016/s0022-5347(01)64485-9
Abstract
We retrospectively reviewed 104 cases of superficial bladder cancer to ascertain whether the Ki-67 labeling index predicts recurrence and progression. Archival specimens from superficial bladder cancer cases were immunostained with Ki-67. The recurrence rate was significantly higher in cases with a Ki-67 labeling index of 5.35 or greater than in those with a value less than 5.35 (p <0.001). The recurrence rate at 2 years was 70% in cases with a Ki-67 labeling index of 5.35 or greater and 22% in those with an index less than 5.35 (p <0.001). Using multivariate analysis the index predicted recurrence of bladder cancer (p <0.005). Median Ki-67 labeling index in cases with progression was significantly higher than in those without progression (p <0.01). The Ki-67 labeling index is an independent predictive factor for recurrence of superficial bladder cancer.Keywords
This publication has 19 references indexed in Scilit:
- Predictability of Recurrent and Progressive Disease in Individual Patients with Primary Superficial Bladder CancerJournal of Urology, 1993
- Prognostic factors in bladder carcinoma: Histologic parameters and expression of a cell cycle‐related nuclear antigen (Ki‐67)The Journal of Pathology, 1992
- Cell Proliferation of Human Bladder Tumors Determined by Brdurd and Ki-67 ImmunostainingJournal of Urology, 1991
- Growth Fractions of Transitional Cell Carcinomas of the Bladder Defined by the Monoclonal Antibody KI-67Journal of Urology, 1990
- Cell Cycling in Bladder Carcinoma Determined by Monoclonal Antibody Ki67British Journal of Urology, 1990
- Growth fractions in gastric carcinomas determined with monoclonal antibody Ki-67Cancer, 1990
- Superficial Bladder Cancer: Progression and RecurrenceJournal of Urology, 1983
- Prognostic Factors in Superficial Bladder Tumors. A Study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative GroupJournal of Urology, 1983
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983
- Factors Influencing the Recurrence Rate of Bladder CancerJournal of Urology, 1980